🚀 From Google Podcasts to Moon FM in No Time: Your Hassle-Free Migration Guide
👉

Hematologic Oncology Update

Dr. Neil Love

This series bridges the gap between research and patient care by providing medical oncologists with access to important information on relevant advances in the treatment of hematologic malignancies.

  • 56 minutes 14 seconds
    What Clinicians Want to Know About the Current and Future Role of EZH1/2 Inhibitors in the Care of Patients with Lymphoma
    Dr Gilles Salles from the Memorial Sloan Kettering Cancer Center in New York, New York, reviews current and novel EZH1/2 inhibitor-based treatment strategies for follicular lymphoma.
    8 November 2024, 8:46 pm
  • 57 minutes 58 seconds
    Practical Perspectives: Optimizing the Role of BTK Inhibitors in the Management of Mantle Cell Lymphoma
    Dr Tycel Phillips from the City of Hope Comprehensive Cancer Center in Duarte, California, and Dr Michael Wang from the University of Texas MD Anderson Cancer Center in Houston discuss the current role of Bruton tyrosine kinase inhibitors for the management of newly diagnosed and relapsed/refractory mantle cell lymphoma.
    30 October 2024, 7:27 pm
  • 1 hour 49 minutes
    Practical Perspectives: Current Management of Chronic Myeloid Leukemia
    Drs Bhavana (Tina) Bhatnagar, Amanda Blackmon, Jorge Cortes, Michael J Mauro and Neil P Shah discuss recent updates on clinical treatment strategies for chronic myeloid leukemia.
    24 October 2024, 7:58 pm
  • 46 minutes 32 seconds
    Oncology Today with Dr Neil Love: Peripheral T-Cell Lymphoma
    Dr Stephen Horwitz from Memorial Sloan Kettering Cancer Center in New York, New York, discusses management strategies for previously untreated and relapsed peripheral T-cell lymphomas.
    17 October 2024, 7:12 pm
  • 58 minutes 58 seconds
    Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 1 of a 3-Part Series
    Dr Matthew S Davids from Dana-Farber Cancer Institute in Boston, Massachusetts, reviews current available data and ongoing investigational treatment approaches for chronic lymphocytic leukemia.
    10 October 2024, 6:40 pm
  • 1 hour 2 minutes
    Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma
    Dr Jesús G Berdeja from the Greco-Hainsworth Tennessee Oncology Centers for Research in Nashville and Dr Thomas Martin from UCSF Helen Diller Family Comprehensive Cancer Center in San Francisco discuss the most relevant new data sets and advances in multiple myeloma.
    12 August 2024, 7:15 pm
  • 1 hour 49 seconds
    RTP Live from Chicago: Investigator Perspectives on the Role of Bispecific Antibodies in the Management of Lymphoma
    Dr Joshua Brody from the Tisch Cancer Institute at Mount Sinai in New York, New York, Dr Ian W Flinn from OneOncology in Nashville, Tennessee, and Dr Tycel Phillips from the City of Hope Comprehensive Cancer Center in Duarte, California, discuss recent updates on available and novel treatment strategies for various lymphomas.
    12 July 2024, 7:19 pm
  • 1 hour 6 seconds
    Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Myelofibrosis
    Dr Aaron T Gerds from the Cleveland Clinic Taussig Cancer Institute in Cleveland, Ohio, discusses recent updates on available and novel treatment strategies for myelofibrosis.
    2 July 2024, 7:11 pm
  • 1 hour 16 minutes
    Oncology Today with Dr Neil Love: Key Presentations on Lymphoma from Recent Major Conferences
    Dr Andrew D Zelenetz from Memorial Sloan Kettering Cancer Center in New York City discusses recent updates on available and emerging treatment strategies for various lymphomas.
    29 May 2024, 8:20 pm
  • 33 minutes 54 seconds
    Oncology Today with Dr Neil Love: Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Dr Elias Jabbour from the University of Texas MD Anderson Cancer Center in Houston discusses recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
    28 May 2024, 7:17 pm
  • 42 minutes 8 seconds
    Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Multiple Myeloma
    Dr Joshua Richter from the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai in New York, New York, discusses the role of bispecific antibodies in multiple myeloma.
    24 May 2024, 4:31 pm
  • More Episodes? Get the App
About Hematologic Oncology Update
Links
Listeners Also Subscribed To
© MoonFM 2024. All rights reserved.